Loading...
XNAS
RXST
Market cap206mUSD
Jul 10, Last price  
4.95USD
1D
-2.56%
1Q
-27.53%
IPO
-71.42%
Name

Rxsight Inc

Chart & Performance

D1W1MN
XNAS:RXST chart
P/E
P/S
1.52
EPS
Div Yield, %
Shrs. gr., 5y
16.64%
Rev. gr., 5y
55.74%
Revenues
134m
-3.89%
2,241,00014,678,00022,593,00049,005,00089,077,000139,927,000134,477,000
Net income
-39m
L+41.84%
126,220,00027,575,000-48,688,000-66,756,000-48,608,000-27,455,000-38,943,000
CFO
-16m
L-8.47%
-40,619,000-35,203,000-44,708,000-58,850,000-41,593,000-16,946,000-15,511,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
IPO date
Jul 30, 2021
Employees
292
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT